Our thoughts and observations on business, partners, productivity, life sciences, & more
ALL
Foundry
Featured in

Foundry
The New Rules of Engagement: FDA Guidance in the Age of AI Medical Content
AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.

Foundry
AI Evals: What We Learned Building AI for Pharma Content Workflows
Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles familiar in regulated systems.

Foundry
AI Copilots vs. Agents in Pharma: What Functional Teams Actually Need to Know
Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Featured In
Why Life Sciences Needs Its Own Integrated Development Environment
Fragmented medical workflows limit AI. Vertical IDEs unify context, improve traceability, reduce risk, and enable reliable agent-driven content creation.

Featured In
Bridging The AI Divide: What It Really Takes To Get AI Agents Into Production
95% of AI pilots fail; success requires agents with context, tool integration, guardrails, usable interfaces, and focus beyond prototypes.

Featured In
When AI Meets Life Sciences: Separating Hype From Reality
AI turns chaotic data into insight at scale, but human judgment, integration challenges, and accuracy constraints define success.
Our thoughts and observations on business, partners, productivity, life sciences, & more
ALL
Foundry
Featured in

Foundry
The New Rules of Engagement: FDA Guidance in the Age of AI Medical Content
AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.

Foundry
AI Evals: What We Learned Building AI for Pharma Content Workflows
Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles familiar in regulated systems.

Foundry
AI Copilots vs. Agents in Pharma: What Functional Teams Actually Need to Know
Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Featured In
Why Life Sciences Needs Its Own Integrated Development Environment
Fragmented medical workflows limit AI. Vertical IDEs unify context, improve traceability, reduce risk, and enable reliable agent-driven content creation.

Featured In
Bridging The AI Divide: What It Really Takes To Get AI Agents Into Production
95% of AI pilots fail; success requires agents with context, tool integration, guardrails, usable interfaces, and focus beyond prototypes.

Featured In
When AI Meets Life Sciences: Separating Hype From Reality
AI turns chaotic data into insight at scale, but human judgment, integration challenges, and accuracy constraints define success.
Our thoughts and observations on business, partners, productivity, life sciences, & more
ALL
Foundry
Featured in

Foundry
The New Rules of Engagement: FDA Guidance in the Age of AI Medical Content
AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.

Foundry
AI Evals: What We Learned Building AI for Pharma Content Workflows
Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles familiar in regulated systems.

Foundry
AI Copilots vs. Agents in Pharma: What Functional Teams Actually Need to Know
Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Featured In
Why Life Sciences Needs Its Own Integrated Development Environment
Fragmented medical workflows limit AI. Vertical IDEs unify context, improve traceability, reduce risk, and enable reliable agent-driven content creation.

Featured In
Bridging The AI Divide: What It Really Takes To Get AI Agents Into Production
95% of AI pilots fail; success requires agents with context, tool integration, guardrails, usable interfaces, and focus beyond prototypes.

Featured In
When AI Meets Life Sciences: Separating Hype From Reality
AI turns chaotic data into insight at scale, but human judgment, integration challenges, and accuracy constraints define success.
Our thoughts and observations on business, partners, productivity, life sciences, & more
ALL
Foundry
Featured in

Foundry
The New Rules of Engagement: FDA Guidance in the Age of AI Medical Content
AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.

Foundry
AI Evals: What We Learned Building AI for Pharma Content Workflows
Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles familiar in regulated systems.

Foundry
AI Copilots vs. Agents in Pharma: What Functional Teams Actually Need to Know
Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Featured In
Why Life Sciences Needs Its Own Integrated Development Environment
Fragmented medical workflows limit AI. Vertical IDEs unify context, improve traceability, reduce risk, and enable reliable agent-driven content creation.

Featured In
Bridging The AI Divide: What It Really Takes To Get AI Agents Into Production
95% of AI pilots fail; success requires agents with context, tool integration, guardrails, usable interfaces, and focus beyond prototypes.

Featured In
When AI Meets Life Sciences: Separating Hype From Reality
AI turns chaotic data into insight at scale, but human judgment, integration challenges, and accuracy constraints define success.
Our thoughts and observations on business, partners, productivity, life sciences, & more
ALL
Foundry
Featured in

Foundry
The New Rules of Engagement: FDA Guidance in the Age of AI Medical Content
AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.

Foundry
AI Evals: What We Learned Building AI for Pharma Content Workflows
Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles familiar in regulated systems.

Foundry
AI Copilots vs. Agents in Pharma: What Functional Teams Actually Need to Know
Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Featured In
Why Life Sciences Needs Its Own Integrated Development Environment
Fragmented medical workflows limit AI. Vertical IDEs unify context, improve traceability, reduce risk, and enable reliable agent-driven content creation.

Featured In
Bridging The AI Divide: What It Really Takes To Get AI Agents Into Production
95% of AI pilots fail; success requires agents with context, tool integration, guardrails, usable interfaces, and focus beyond prototypes.

Featured In
When AI Meets Life Sciences: Separating Hype From Reality
AI turns chaotic data into insight at scale, but human judgment, integration challenges, and accuracy constraints define success.
Resources
Legal
Company








See Logicflo in action
Faster workflows. Sharper Science.
Resources
Legal
Company






See Logicflo in action
Faster workflows. Sharper Science.

See Logicflo in action
Faster workflows. Sharper Science.

Resources







See Logicflo in action
Faster workflows. Sharper Science.

See Logicflo in action
Faster workflows. Sharper Science.